Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.07 · 8-K

Electromed, Inc.

ELMDNYSE_AMERICANEQUITYCurrent

Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. At the annual meeting of shareholders of Electromed, Inc. (the “Company”) held on November 13, 2026, the following proposals, each as described in further detail in the definitive proxy statement filed on September 29, 2026, were voted upon by our shareholders as set forth below:…

Filed Nov 16, 2026Accepted Nov 16, 2026, 4:07 PM ESTCIK 1488917Accession 0001437749-26-037162
Share

Company context

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Current securities

Recent company filings

  1. S-8 filingNov 16, 2026
  2. 10-Q filingNov 10, 2026
  3. Results of Operations and Financial Condition · Regulation FD DisclosureNov 10, 2026
  4. DEF 14A filingSep 29, 2026
  5. DEFA14A filingSep 29, 2026

Registered securities in this filing

ELECTROMED, INC. · 8-K · Filed 2026-11-16

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
ELMD
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: d20268K

Dimensions: Not supplied

Accession 000143774926037162 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.07

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders. At the annual meeting of shareholders of Electromed, Inc. (the “Company”) held on November 13, 2026, the following proposals, each as described in further detail in the definitive proxy statement filed on September 29, 2026, were voted upon by our shareholders as set forth below: The following individuals designated by our Board of Directors ("Board") as nominees for director were elected for a one-year term or until a successor has been elected and qualified, thereby setting the number of directors at seven, with voting as follows: Name For Withheld Broker Non-Votes ────────────────────────────────────────────────────────────────────────────── James L. Cunniff 4,943,959 71,507 1,563,582 Stan K. Erickson 4,908,618 106,848 1,563,582 Gregory J. Fluet 4,561,739 453,727 1,563,582 Joseph L. Galatowitsch 4,955,310 60,156 1,563,582 Kathleen S. Skarvan 3,369,973 1,645,493 1,563,582 Kathleen A. Tune 4,953,163 62,303 1,563,582 Andrea M. Walsh 4,949,906 65,560 1,563,582 Our shareholders ratified the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2027, with voting as follows: ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── For Against Abstain ─────────────────────────────────────── 6,544,291 22,740 12,017 Our shareholders approved, on a non-binding and advisory basis, our executive compensation, with voting as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 4,520,178 200,335 294,953 1,563,582 Our shareholders approved the Electromed, Inc. Employee Stock Purchase Plan, with voting as follows: For Against Abstain Broker Non-Votes ───────────────────────────────────────────────────────────── 4,977,670 23,478 14,318 1,563,582 Following the completion of the annual meeting, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Joseph L. Galatowitsch to serve as an additional member of the Nominating and Governance Committee and designated Kathleen A. Tune to serve as chair of the Personnel and Compensation Committee. No other changes to committee membership or leadership are currently planned.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.